yes that was not disclosed in anything I read . It was protected I assume as a commercial in confidence contractual clause between two parties. Ridiculous given it is extremely material to exposures of Coy . They have issued bonds contingent that could get affected by a change control as well .
QIN has argued , that Galdarma termination was not material to share price as:
the revenue was very small,
the contract not binding and
the buyer had an unforeseen but clear conflict of interest with its main brand
it had not written in any value for it in 2017 forecast.
How could FW and CEO for Santalis hold it back from totally relevant meetings and so many other reporting requirements under the communications policy?. How could FW not inform the Board. ? Why was QIN late in getting a suspension?
Incomprehensible to me.
response was what I expected after our discussions on the information.
QIN Price at posting:
29.5¢ Sentiment: None Disclosure: Held
